Loss to Follow-Up in Patients With Proliferative Diabetic Retinopathy or Diabetic Macular Edema.

ABSTRACT:

Importance

Effective management of proliferative diabetic retinopathy (PDR) and diabetic macular edema (DME) requires reliable patient follow-up to prevent disease progression.

Objective

To investigate the sociodemographic and clinical factors associated with being lost to follow-up (LTFU) among individuals with PDR or DME treated with anti-vascular endothelial growth factor (VEGF) intravitreal injections (IVIs) or panretinal photocoagulation (PRP).

Design, setting, and participants

This cohort study included a multicenter, retrospective review of patients with PDR or DME treated in Toronto, Canada, from January 1, 2012, to December 31, 2021. Data were analyzed from February 1 to May 31, 2024.

Exposures

All patients received at least 1 anti-VEGF IVI or PRP sess

SUBMITTER: Huang RS 

PROVIDER: S-EPMC11645645 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature